MedPath

Exploring the Feasibility of Voice-Controlled Intelligent Personal Assistants for delivery of home-based lifestyle interventions in older adults with type II diabetes

Not Applicable
Completed
Conditions
type 2 diabetes mellitus
Obesity
Diet and Nutrition - Obesity
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12621000307808
Lead Sponsor
Deakin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Prospective participants must be aged 50-75 years; English-speaking; have a body mass index greater than or equal to 30 kg/m2, able to walk across a room unaided; with access to a smartphone connected to an internet network; willing to complete a 12-week lifestyle intervention and also be willing to participate should they be randomised to either intervention arm.

Exclusion Criteria

Participants are ineligible if they report currently being unable to walk across a room unaided; are non-English speaking or have difficulty communicating with study personnel or a VIPA device due to speech or hearing problems; unwilling to be randomised; planning to be away from the VIPA device for greater than or equal to 4 weeks during the 12-week intervention period; severe knee or hip osteoarthritis (awaiting a joint replacement) that would interfere with ability to complete exercise; recent fracture (past 3 months) limiting exercise; renal disease requiring dialysis; and any other disorder of such severity that life expectancy is less than 12 months, or any cognitive or physical impairment or disability that in the opinion of the study investigators would result in the participant having difficulty interacting with Buddy Link or performing unsupervised exercise safely. Participants who answer ‘yes’ to any of six questions on the Exercise and Sports Science Australia (ESSA) pre-exercise screening tool will also be excluded. This is a validated and recommended pre-exercise screening tool for ensuring safety for exercise at moderate exertion, endorsed by Australia’s peak exercise body (ESSA).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility as measured by recruitment greater than or equal to 20% of eligible participants. This will be determined by an audit of the study database.[follow-up (12 weeks post-intervention commencement) ];Feasibility as measured by greater than or equal to 70% retention in the study, this will be determined by an audit of the study database.[follow-up (12 weeks post-intervention commencement) ];Feasibility as measured by completion of greater than or equal to 66% of prescribed exercise and dietary advice,this will be determined by an audit of the study database.[follow-up (12 weeks post-intervention commencement) ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath